The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Related Articles
Fumiko Ladd Chino: 2025 ASCO JCO Journals Editorial Fellow Application is OPEN – OncoDaily
Fumiko Ladd Chino: 2025 ASCO JCO Journals Editorial Fellow Application is OPEN / ASCO, cancer, Fumiko Ladd Chino, Narrative Medicine, OncoDaily, Oncology
Cancer associated fibroblasts drive epithelial to mesenchymal transition and classical to basal change in pancreatic ductal adenocarcinoma cells with loss of IL-8 expression
Pancreatic ductal adenocarcinoma (PDAC) carries an extremely poor prognosis, in part resulting from cellular heterogeneity that supports overall tumorigenicity. Cancer associated fibroblasts (CAF) are key…
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial – PubMed
Patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) have poor outcomes. Gemcitabine + oxaliplatin (GemOx) with rituximab, a standard salvage therapy, yields…
A time for truth and reconciliation
Trump’s return to the White House augurs the ‘apokálypsis’ of the ancien regime’s secrets
Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and…
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Is Preventative Oophorectomy Safe? – OncoDaily
Is Preventative Oophorectomy Safe? / cancer, Dana-Farber’s Breast Oncology Center, Douglas E. Drachman, Erica L. Mayer, Megan E. Tesch, OncoDaily, Oncology,
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries | JCO Oncology Practice
PURPOSEFinancial toxicity (FT) of cancer treatment likely affects more patients in low- and middle-income countries (LMICs); however, most of the research on FT comes from…
Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions
Although there is no formal definition, financial toxicity (FT) refers to the detrimental effects of the excess financial strain caused by the diagnosis of cancer…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
